| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/22/2011 | EP1556402B1 In vivo gene silencing by chemically modified and stable sirna |
| 06/22/2011 | EP1546174B1 Methods and compositions for rna interference |
| 06/22/2011 | EP1341526B1 Pharmaceutical compositions for the oral delivery of calcitonin |
| 06/22/2011 | EP1328545B1 Human gene critical to fertility |
| 06/22/2011 | EP1324771B1 Therapeutic and tolerance inducing antibodies |
| 06/22/2011 | EP1207876B1 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing |
| 06/22/2011 | EP1109827B1 Bioactive peptides |
| 06/22/2011 | CN1891714B Ligand for herpes simplex virus entry mediator and methods of use |
| 06/22/2011 | CN1820024B Novel poly(ethylene glycol) modified compounds and uses thereof |
| 06/22/2011 | CN1560078B Tumor antigen based on products of the tumor suppressor gene WT1 |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN102105582A Hyperglycosylated human coagulation factor IX |
| 06/22/2011 | CN102105492A Impaired wound healing compositions and treatments |
| 06/22/2011 | CN102105487A CRKL targeting peptides |
| 06/22/2011 | CN102105486A Peptidylarginine deiminase (PAD) inhibitors |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102105164A Thrombopoietic activity of tyrosyl-TRNA synthetase polypeptides |
| 06/22/2011 | CN102105163A Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof |
| 06/22/2011 | CN102105162A The use of Wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 06/22/2011 | CN102105161A Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 06/22/2011 | CN102105160A Compositions and methods for increasing serum antioxidant concentrations |
| 06/22/2011 | CN102105159A GIP-based mixed agonists for treatment of metabolic disorders and obesity |
| 06/22/2011 | CN102105148A Therapeutic combination comprising an AURORA kinase inhibitor and antiproliferative agents |
| 06/22/2011 | CN102105141A Method of producing thrombin-immobilized bioabsorbable sheet preparation |
| 06/22/2011 | CN102102119A Bird's nest oligopeptide composition and preparation method and use thereof |
| 06/22/2011 | CN102101886A Variable-conformation recombinant interferon crystal, and three-dimensional structure and use thereof |
| 06/22/2011 | CN102101885A Human interleukin-II mutant of low-inductivity suppressor T cells and use thereof |
| 06/22/2011 | CN102101884A Preparation method and use of donkey-hide gelatin polypeptide |
| 06/22/2011 | CN102101881A Preparation and application of pidotimod potassium salt |
| 06/22/2011 | CN102100913A Target spot and medicine for treating cerebral injury |
| 06/22/2011 | CN102100908A Protein composition |
| 06/22/2011 | CN102100907A Composition of oral pharmacologic active agent |
| 06/22/2011 | CN102100906A Medicinal preparation of exenatide and preparation method thereof |
| 06/22/2011 | CN102100905A Novel compound antimicrobial preparation |
| 06/22/2011 | CN102100904A Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 06/22/2011 | CN102100903A Capsule preparation of pidotimod sylvite and preparation thereof |
| 06/22/2011 | CN102100687A Medicine composition with function of exterminating oral helicobacter pylori and application thereof |
| 06/22/2011 | CN102100672A Vascular endothelial growth factor chitosan microsphere and application thereof |
| 06/22/2011 | CN102100669A Immunity liposome, and preparation method and application thereof |
| 06/22/2011 | CN102100324A Composition with strong antioxidant activity and application thereof |
| 06/22/2011 | CN101716156B Ubenimex dispersive tablet composition |
| 06/22/2011 | CN101434650B Bursa pentapeptide, deriving peptide thereof and use thereof |
| 06/22/2011 | CN101396378B Nano gene peptides products and preparation method and use thereof |
| 06/22/2011 | CN101327315B Use of maltose binding protein as immunopotentiator |
| 06/22/2011 | CN101284876B Fusion protein Penharpin, preparation method and use |
| 06/22/2011 | CN101264316B Preparation of medicinal protolysate |
| 06/22/2011 | CN101239182B Calcium phosphate delivery vehicles for osteoinductive proteins |
| 06/22/2011 | CN101173008B Double-function amalgamation protein, preparation method and application thereof |
| 06/22/2011 | CN101144081B Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 06/22/2011 | CN101130061B Segmented intestine targeted drug feeding preparation of myocardium protein polypeptide and method of producing the same |
| 06/22/2011 | CN101115767B vWFA and/or ANT_IG domain containing proteins |
| 06/22/2011 | CN101115495B Method to enhance the bone formation activity of bmp by RUNX2 acetylation |
| 06/22/2011 | CN101020047B Health food containing calcium reinforcing agent |
| 06/21/2011 | US7964729 Sox-based kinase sensor |
| 06/21/2011 | US7964717 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene |
| 06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
| 06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964702 Phalloidin derivatives and methods for their synthesis |
| 06/21/2011 | US7964701 Exposing the cancer cell to a peptide has antiestrotrophic activity; inhibit estrogen receptor dependent cell proliferation; breast cancer |
| 06/21/2011 | US7964632 Methods of treatment using a prodrug of an excitatory amino acid |
| 06/21/2011 | US7964578 Conjugates and compositions for cellular delivery |
| 06/21/2011 | US7964576 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 06/21/2011 | US7964573 Using presence of single nucleotide polymorphism in transient receptor potential channel gene(TRPC) as diagnostic/prognostic tool in detecting idiopathic pulmonary arterial hypertension (IPAH) |
| 06/21/2011 | US7964572 High affinity nucleic acid ligands of complement system proteins |
| 06/21/2011 | US7964570 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
| 06/21/2011 | US7964567 Monomethylvaline compounds capable of conjugation to ligands |
| 06/21/2011 | US7964566 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases |
| 06/21/2011 | US7964565 Method of inhibiting inflammation in a mammal by administering Bcl protein |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964563 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 06/21/2011 | US7964562 folliculogenesis and follicular maturation without ovarian hyperstimulation; contain various FSH-to-hCG ratios and a carrier; enable the practitioner to optimize ovulatory stimulation in flexible manner |
| 06/21/2011 | US7964561 Protein formulations for use at elevated temperatures |
| 06/21/2011 | US7964560 Hepatitis C virus inhibitors |
| 06/21/2011 | US7964559 MVL, an antiviral protein from a cyanobacterium |
| 06/21/2011 | US7964558 Therapeutic applications for C-peptide |
| 06/21/2011 | US7964557 Administering adiponectin; inhibitory effect of adiponectin on choroidal angiogenesis or choroidal neovascularization |
| 06/21/2011 | US7964556 Antimicrobial peptides and use thereof |
| 06/21/2011 | US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
| 06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
| 06/21/2011 | US7964377 Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF |
| 06/21/2011 | US7964367 Human p51 genes and gene products thereof |
| 06/21/2011 | US7964366 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| 06/21/2011 | US7964359 Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance |
| 06/21/2011 | US7964199 Therapeutic composition comprising a botulinum neurotoxin |
| 06/21/2011 | US7964192 Prevention and treatment of amyloidgenic disease |
| 06/21/2011 | US7964190 Administering mixtures of antibodies and tumor necrosis factors, immunosuppressants, antibiotics, antiinflammatory agents, cytokines, angiogenesis inhibitors or fibroblast growth factors; prophylaxis of graft versus host disease |
| 06/21/2011 | US7964189 Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women |
| 06/21/2011 | US7964188 Use of placental alkaline phosphatase to promote skin cell proliferation |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 06/21/2011 | US7964184 Cysteine variants of interferon-gamma |
| 06/21/2011 | US7964183 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 06/21/2011 | US7964181 Amino acid surrogates for peptidic constructs |
| 06/21/2011 | US7963997 Device for regeneration of articular cartilage and other tissue |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2578967C Antimicrobial cementitious compositions |
| 06/21/2011 | CA2523098C Skin collagen production promoter |
| 06/21/2011 | CA2506481C Method of treatment of conditions by administration of streptolysin o |